DFX Intelligence

Clare Ozawa

Managing Member, Versant Vantage I Gp-Gp, Llcat Versant Venture Management, LLC· CA

As of 2026-09-23 · this person's identity; each section below carries its own date

Current roles: 10
Investments attributed: 2
Board seats: 2

Ask DFX about this View relationships Find contacts Investments Board seats

As of 2026-09-23 · this person's identity; each section below carries its own date

12 additional roles and seats

Every relationship, signal and contact on this record, with the source on each.

Includes 3 days of DFX Intelligence. Then $199/month unless canceled.

What matters now

1 deal
12 months
1 investment attributed in the last 12 months; latest Lycia Therapeutics round on 25 Jun 2026.
A partner with a recent deal is actively writing cheques now.
Factfunding announcements and Form D naming the personFor Founders, co-investorsInvestments →
2 boards
seats on record
Sits on 2 boards on record, the latest Lycia Therapeutics on 25 Jun 2026.
Board seats show where this partner holds governance, not only a cheque.
InferenceForm D directors and board-seat attributionsFor Founders, co-investorsBoard seats →

Relationship network

12 connected entities2 observed investment recordsinvestment records 2024 to 2026

From the roles sources name this person in, the investments a source attributes to them, and the boards and funds Form D names them on.

Some relationships on this record are counted rather than named here. They open with the full profile.

Click any name or line for the investment records and sources behind it. Line weight is investment records together; dashed lines are inferred.

Reading the network

Organization
Company
Fund or vehicle

Venture relationships are not scored. Each line names its claim: a round led or joined, a board seat or a filing that names the firm, a listing on a portfolio page (dated by when DFX saw it, never by when the investment was made), a disclosed LP commitment, or a co-investor pair counted from observed participations. Observed means a named source says so; Derived means DFX counted it from observed rows; Inferred means a match that may be wrong.

Darker lines were active in the last 24 months or are current; lighter lines are older or undated.

Ask DFX about this network

Which companies and boards is Clare Ozawa connected to?

How am I connected?

Name your firm, a company or a person, and DFX finds the published routes to Clare Ozawa: a shared portfolio company or board, a prior employer, a co-investor, a shared LP or service provider. Every step is a filed or published record with its source; none is a guess about who knows whom.

See how you connect to Clare Ozawa

Includes 3 days of DFX Intelligence. Then $199/month unless canceled.

Drawing the relationship network…

Roles

9 current, 0 past

Versant Venture Management, LLC Managing Member, Versant Vantage Iii Gp-Gp, Llc
Oct 1, 2022 to present · “Schedule A: Ozawa, Clare, MANAGING MEMBER, VERSANT VANTAGE III GP-GP, LLC, since 10/2022, ownership B, control person Y”
Fact Form ADV
Versant Venture Management, LLC Managing Member, Versant Voyageurs Iii Gp-Gp, Llc
Oct 1, 2022 to present · “Schedule A: Ozawa, Clare, MANAGING MEMBER, VERSANT VOYAGEURS III GP-GP, LLC, since 10/2022, ownership B, control person Y”
Fact Form ADV
Versant Venture Management, LLC Managing Member, Versant Ventures Ix Gp-Gp, Llc
Oct 1, 2022 to present · “Schedule A: Ozawa, Clare, MANAGING MEMBER, VERSANT VENTURES IX GP-GP, LLC, since 10/2022, ownership B, control person Y”
Fact Form ADV

Investments attributed to this person

Company	Round	Investor	Attribution	Date	Source
Lycia Therapeutics, Inc.	board only	Versant Venture Management, LLC	strongly supported · board	Jun 25, 2026	Inference sec.gov
858 Therapeutics, Inc.	board only	Versant Venture Management, LLC	strongly supported · board	Jul 11, 2024	Inference sec.gov

Board seats and vehicles

2 boards, 9 vehicles

Lycia Therapeutics, Inc. Director Jun 25, 2026 Inference
858 Therapeutics, Inc. Director Jul 11, 2024 Inference
Versant Venture Capital VII, L.P. Director Sep 17, 2018
Versant Vantage I, L.P. Director Mar 8, 2019
Versant Vantage II, L.P. Executive Officer Nov 18, 2020

Timeline

4 dated entries: events, attributed deals, board seats and role changes

Jun 25, 2026
Board seat at Lycia Therapeutics, Inc. (Versant Venture Management, LLC)
Board seat Inference Lycia Therapeutics, Inc. Form D
Jul 11, 2024
Board seat at 858 Therapeutics, Inc. (Versant Venture Management, LLC)
Board seat Inference 858 Therapeutics, Inc. Form D
Oct 1, 2022
Joined Versant Venture Management, LLC as Managing Member, Versant Vantage Iii Gp-Gp, Llc
Role began Fact Versant Venture Management, LLC Form ADV
Apr 1, 2018
Clare Ozawa joined Schedule A of Versant Venture Management, LLC as Limited Partner, Versant Voyageurs I Gp, Lp
Person joined Fact Versant Venture Management, LLC Form ADV

Record history

1 dated event on the change ledger, latest event first

Person joined
2018-04-01source on record

The ledger records every merge, rename and reclassification this record went through and the dated filings observed on it, so the identity on this page can be traced to the records it was built from. The ledger's own sentences name other records, so they show with the names.